Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$136K Buy
604
+10
+2% +$2.49K ﹤0.01% 836
2025
Q4
$143K Buy
594
+158
+36% +$40.4K ﹤0.01% 791
2025
Q3
$119K Buy
436
+158
+57% +$43.2K ﹤0.01% 788
2025
Q2
$71.7K Sell
278
-4
-1% -$954 ﹤0.01% 967
2025
Q1
$63.1K Buy
282
+35
+14% +$8.17K ﹤0.01% 958
2024
Q4
$56.5K Sell
247
-2,218
-90% -$534K ﹤0.01% 871
2024
Q3
$602K Buy
2,465
+47
+2% +$10.5K 0.01% 377
2024
Q2
$463K Buy
2,418
+143
+6% +$29K 0.01% 404
2024
Q1
$451K Buy
2,275
+1
+0% +$183 0.01% 426
2023
Q4
$391K Sell
2,274
-81
-3% -$12.4K 0.01% 453
2023
Q3
$348K Sell
2,355
-95
-4% -$17.2K 0.01% 454
2023
Q2
$535K Hold
2,450
0.01% 408
2023
Q1
$537K Sell
2,450
-7
-0.3% -$1.52K 0.01% 404
2022
Q4
$512K Sell
2,457
-921
-27% -$202K 0.01% 412
2022
Q3
$738K Sell
3,378
-3,639
-52% -$828K 0.01% 386
2022
Q2
$1.47M Buy
7,017
+949
+16% +$202K 0.02% 324
2022
Q1
$1.47M Sell
6,068
-193
-3% -$46.7K 0.02% 335
2021
Q4
$1.63M Buy
+6,261
New +$1.62M 0.02% 328

Other funds holding RMD

UMB Bank's RMD Position: Q1 2026 in Review

UMB Bank increased its ResMed (RMD) stake by 1.7% in Q1 2026, buying an estimated $2.49K and bringing the position to 604 shares worth $136K. The position accounts for ﹤0.01% of the portfolio, ranked #836.

UMB Bank first reported a position in RMD in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.63M in Q4 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • UMB Bank held 604 shares of ResMed worth $136K as of Q1 2026.
  • UMB Bank bought 10 ResMed shares in Q1 2026, an estimated $2.49K.
  • ResMed made up ﹤0.01% of UMB Bank's portfolio in Q1 2026, its #836 holding.
  • UMB Bank first reported a position in ResMed in Q4 2021 and has held it in 18 quarters since.
  • UMB Bank's ResMed position peaked at $1.63M in Q4 2021.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.